Search

everythinglearnresearchcommunity

for

Search:↓

Follicular unit grafting is a procedure used to treat hair loss, where small hair grafts are placed into the scalp, with future treatments likely to involve smaller incisions and cell-based therapies.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The new hydrogel treatment promotes faster hair growth and better skin health for hair loss.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

A specific microRNA, chi-miR-30b-5p, slows down the growth of hair-related cells by affecting the CaMKIIδ gene in cashmere goats.

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Higher aldosterone levels in urine are linked to a nondipper blood pressure pattern in healthy people.

People with non-dipper hypertension have higher aldosterone levels, more strain on their heart's venous system, and increased risk of endothelial dysfunction.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Stopping minoxidil and draining fluid around the heart can save lives in rare cases.

A man's unusual scalp folds caused by a skin condition were treated with surgery and remained unchanged two years later.

Mice with human chymase had a higher death rate when exposed to a toxin compared to normal mice.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A man with Isaac's syndrome affecting only one side of his body improved after immune system-targeted treatment.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

PRFM may help treat hair loss, especially in mild cases.

Three specific genetic variants cause severe skin issues in children with EBS, highlighting the need for early genetic screening.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Isotretinoin effectively reduces acne but causes dry skin, higher skin pH, more redness, and hair loss.

Stopping tamsulosin one month before cataract surgery reduces eye surgery complications in rats.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Finasteride works best in 6 months and lasts 6 years.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.